PA
BYRN icon

PharVision Advisers’s Byrna Technologies BYRN Stock Holding History

PharVision Advisers’s Portfolio BYRN Stock Details BYRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.8K Buy
+12,191
New +$74.9K 1.54% 32
2025
Q4 		– Sell
-18,913
Closed -$419K – 721
2025
Q3 		$419K Buy
+18,913
New +$420K 0.24% 64

Other funds holding BYRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.5B AUM 24.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PharVision Advisers's BYRN Position: Q2 2026 in Review

PharVision Advisers opened a new position in Byrna Technologies (BYRN) in Q2 2026: 12,191 shares worth $81.8K. The stake represents 1.54% of the portfolio and ranks #32 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in BYRN as recently as Q3 2025.

PharVision Advisers first reported a position in BYRN in Q3 2025 and has held it in 2 quarters since. The position peaked at $419K in Q3 2025. 107 funds tracked by Wall St. Rank hold BYRN as of Q2 2026.

  • PharVision Advisers held 12,191 shares of Byrna Technologies worth $81.8K as of Q2 2026.
  • Byrna Technologies was a new PharVision Advisers position in Q2 2026.
  • Byrna Technologies made up 1.54% of PharVision Advisers's portfolio in Q2 2026, its #32 holding.
  • PharVision Advisers first reported a position in Byrna Technologies in Q3 2025 and has held it in 2 quarters since.
  • PharVision Advisers's Byrna Technologies position peaked at $419K in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Byrna Technologies as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.